Literature DB >> 26196231

Complementation of the human adenovirus type 5 VA RNAI defect by the Vaccinia virus E3L protein and serotype-specific VA RNAIs.

Raviteja Inturi1, Wael Kamel1, Göran Akusjärvi1, Tanel Punga2.   

Abstract

Human adenoviruses (HAdVs) encode for multifunctional non-coding virus-associated (VA) RNAs, which function as powerful suppressors of the cellular interferon (IFN) and RNA interference (RNAi) systems. In this study we tested the ability of various plant and animal virus encoded RNAi and IFN suppressor proteins to functionally substitute for the HAdV-5 VA RNAI. Our results revealed that only the Vaccinia virus (VACV) E3L protein was able to substitute for the HAdV-5 VA RNAI functions in virus-infected cells. Interestingly, the E3L protein rescues the translational defect but does not stimulate viral capsid mRNA accumulation observed with VA RNA. We further show that the E3L C-terminal region containing the dsRNA-binding domain is needed to enhance VA RNAI mutant virus replication. Additionally, we show that the HAdV-4 and HAdV-37 VA RNAI are more effective than the HAdV-5 VA RNAI in rescuing virus replication.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenovirus; E3L protein; Interferon response; RNAi; VA RNA; Vaccinia virus

Mesh:

Substances:

Year:  2015        PMID: 26196231     DOI: 10.1016/j.virol.2015.07.002

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  4 in total

1.  Human Adenovirus Infection Causes Cellular E3 Ubiquitin Ligase MKRN1 Degradation Involving the Viral Core Protein pVII.

Authors:  Raviteja Inturi; Kwangchol Mun; Katrin Singethan; Sabrina Schreiner; Tanel Punga
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

2.  Cellular Zinc Finger Protein 622 Hinders Human Adenovirus Lytic Growth and Limits Binding of the Viral pVII Protein to Virus DNA.

Authors:  Kwangchol Mun; Tanel Punga
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

3.  Efficacy of recombinant adenovirus expressing a fusion gene from GM-CSF and Epstein-Barr virus LMP2A in a mouse tumor model.

Authors:  Qingjie Xue; Xiuzhen Li; Chunqing Yang; Bingyuan Ji; Yunqing Li; Yingchun Yan; Xinxin Yang; Chunmei Wang; Ting Chen
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

4.  Structural Insights into Human Adenovirus Type 4 Virus-Associated RNA I.

Authors:  Helen Bergquist; Raviteja Inturi; Rula Zain; Tanel Punga
Journal:  Int J Mol Sci       Date:  2022-03-13       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.